Kim-Fuchs Corina, Le Caroline P, Pimentel Matthew A, Shackleford David, Ferrari Davide, Angst Eliane, Hollande Frédéric, Sloan Erica K
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia; Department of Visceral Surgery and Medicine, University Hospital Bern, Bern, Switzerland.
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Brain Behav Immun. 2014 Aug;40:40-7. doi: 10.1016/j.bbi.2014.02.019. Epub 2014 Mar 17.
Pancreatic cancer cells intimately interact with a complex microenvironment that influences pancreatic cancer progression. The pancreas is innervated by fibers of the sympathetic nervous system (SNS) and pancreatic cancer cells have receptors for SNS neurotransmitters which suggests that pancreatic cancer may be sensitive to neural signaling. In vitro and non-orthotopic in vivo studies showed that neural signaling modulates tumour cell behavior. However the effect of SNS signaling on tumor progression within the pancreatic microenvironment has not previously been investigated. To address this, we used in vivo optical imaging to non-invasively track growth and dissemination of primary pancreatic cancer using an orthotopic mouse model that replicates the complex interaction between pancreatic tumor cells and their microenvironment. Stress-induced neural activation increased primary tumor growth and tumor cell dissemination to normal adjacent pancreas. These effects were associated with increased expression of invasion genes by tumor cells and pancreatic stromal cells. Pharmacological activation of β-adrenergic signaling induced similar effects to chronic stress, and pharmacological β-blockade reversed the effects of chronic stress on pancreatic cancer progression. These findings indicate that neural β-adrenergic signaling regulates pancreatic cancer progression and suggest β-blockade as a novel strategy to complement existing therapies for pancreatic cancer.
胰腺癌细胞与影响胰腺癌进展的复杂微环境密切相互作用。胰腺由交感神经系统(SNS)的纤维支配,并且胰腺癌细胞具有SNS神经递质的受体,这表明胰腺癌可能对神经信号敏感。体外和非原位体内研究表明,神经信号调节肿瘤细胞行为。然而,SNS信号对胰腺微环境内肿瘤进展的影响此前尚未得到研究。为了解决这个问题,我们使用体内光学成像技术,通过一个原位小鼠模型对原发性胰腺癌的生长和扩散进行无创追踪,该模型可复制胰腺肿瘤细胞与其微环境之间的复杂相互作用。应激诱导的神经激活增加了原发性肿瘤的生长以及肿瘤细胞向邻近正常胰腺的扩散。这些效应与肿瘤细胞和胰腺基质细胞中侵袭基因表达的增加有关。β-肾上腺素能信号的药理学激活诱导了与慢性应激相似的效应,而药理学β-阻断逆转了慢性应激对胰腺癌进展的影响。这些发现表明,神经β-肾上腺素能信号调节胰腺癌进展,并提示β-阻断作为一种新策略来补充现有的胰腺癌治疗方法。